Frontotemporal dementia market
Jul 27, 2020
Addressing The Scattered Harbingers of Frontotemporal Dementia
The Frontotemporal dementia market is expected to increase with a CAGR of 21.41% for 7MM during the study period. However, pharma companies such as TauRx Therapeutics, Axon Neuroscience SE, Prevail Therapeutics, Avid Radiopharmaceuticals, and Alector are actively working to buildup the Frontotemporal dementia pipel...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
